Online reports from ADA. Video. Audio.

Medpage today has several reporting journalists and lots of ADA breaking news, most just texts, but also on video interviews, sound tracks. See here some headlines examples on their first page on www – and then there are more information by a click

ADA: Tight Control No Help After Renal Treatment
6/28/2011
SAN DIEGO — Tight glucose control early after kidney transplantation doesn’t improve graft success, researchers found.

——————————————————————————–
ADA: Biologic Slows Type 1 Diabetes
6/28/2011
SAN DIEGO — The arthritis drug abatacept (Orencia) may help delay progression of type 1 diabetes, according to randomized clinical trial results.

——————————————————————————–
ADA: Drug Misses Type 1 Goal, but May Help Beta Cells
6/28/2011
SAN DIEGO — Although treatment with the monoclonal antibody teplizumab doesn’t appear to improve glycemic control or reduce insulin dose among patients with type 1 diabetes, it may still preserve beta-cell function, researchers said here.

——————————————————————————–
ADA: Type 1 Diabetes Vaccine Fails to Show Benefit
6/27/2011
SAN DIEGO — An antigen-based immunotherapy has failed to halt the progression of type 1 diabetes after one year, researchers reported here.

——————————————————————————–
ADA: FDA Artificial Pancreas Initiative InFocus
6/27/2011
SAN DIEGO — In this exclusive InFocus report, Chip Zimliki, PhD, chair of the FDA’s critical path initiative for the artificial pancreas, discusses the agency’s first guidance on premarket approval of closed-loop systems.

——————————————————————————–
ADA: Early Liraglutide Tx Improves Diabetes Control
6/27/2011
SAN DIEGO — Early treatment with the glucagon-like peptide-1 agonist liraglutide (Victoza) appears to improve type 2 diabetic patients’ overall glycemic control when compared with using the injected drug late in the course of the disease, researchers said here.
ADA: Type 2 Diabetics Can Alter Lifestyles
6/27/2011
SAN DIEGO — A short-term lifestyle modification program for overweight diabetic patients seen in clinical practice showed long-term benefits for many of the participants, researchers reported here.

——————————————————————————–
ADA: Docs Worldwide Slow to Start Insulin
6/27/2011
SAN DIEGO — Treatment of diabetes varies greatly in clinical practice worldwide — but there is one constant, researchers said here: Doctors tend to delay treatment with insulin in every region of the globe.

——————————————————————————–
ADA: FDA Unlikely to Zap Pioglitazone
6/26/2011
SAN DIEGO — Bladder cancer risks aren’t likely to send the diabetes drug pioglitazone (Actos) down the same path as rosiglitazone (Avandia), according to this exclusive InFocus report from the American Diabetes Association meeting.

——————————————————————————–
ADA: Diabetes Drug May Help Others Lose Weight
6/26/2011
SAN DIEGO — The diabetes drug liraglutide (Victoza), touted for its weight-loss effects in that patient population, may also help non-diabetic patients keep pounds off, researchers said here.

——————————————————————————–
ADA: Antipsychotics Change Metabolism in Kids
6/26/2011
SAN DIEGO — Antipsychotics appear to increase body fat and increase the risk of metabolic abnormalities in children and adolescents, researchers said here.
1 post
——————————————————————————–
ADA: Type 1 Diabetes Control Tied to Heart Failure Risk
6/26/2011
SAN DIEGO — Tight glucose control in type 1 diabetes could rein in risk of heart failure as a complication of the disease, population-based study results suggested.
ADA: Cheap Generics Boost Price Tag for Brand Names
6/25/2011
SAN DIEGO — Dramatic increases in brand-name drug pricing at pharmacies across the country have followed the low-price generic programs popularized by Wal-Mart, researchers discovered.

——————————————————————————–
ADA: Older Diabetics Better at Keeping Weight Off
6/25/2011
SAN DIEGO — Weight loss among diabetic, overweight patients was most durable in those who lost more than 10% of their body weight in the first year and in those 65 and older, researchers said here.

——————————————————————————–
ADA: Intensive Tx No Better than Good Routine Diabetes Care
6/25/2011
SAN DIEGO — Screening and early intensive management of type 2 diabetes may hold little benefit beyond usual care, perhaps because of more aggressive routine practice, researchers suggested.

——————————————————————————–
ADA: Two Tests Needed to Track Diabetes Progression
6/25/2011
SAN DIEGO — Diagnosing prediabetes with a combination of glycated hemoglobin and impaired fasting glucose may be a more effective predictor of progression to diabetes than either test alone, Japanese researchers found.

——————————————————————————–
ADA: Diet Counseling Aids Glycemic Control
6/25/2011
SAN DIEGO — Intensive dietary counseling in the year following a diagnosis of diabetes improved glycemic control, but adding exercise to the mix didn’t add any extra benefits, researchers said here.
3 posts
——————————————————————————–
347 Million Diabetics Counted Worldwide
6/25/2011
The global prevalence of diabetes reached 347 million in 2008, more than doubling the number of people with diabetes worldwide since 1980, researchers said.
1 post

+++++++++++++++++++++++++++++++++++++++

FOR YOU FREE
www.medpagetoday.com/Endocrinology

eller klicka pa ”lank” nedtill

Allt finns ocksa som app till iphone eller android, mest omfattande bevakning av internationella moten inkl ADA, diabetes i allmanhet.

Sok pa ”Medpage today mobile”

Nyhetsinfo
www red DiabetologNytt

Publicerad: |2011-06-28|